SILVER SPONSOR

link_edited.png
Vitiello ISLB visual-final2.png

About Biocartis

 

Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Biocartis' proprietary MDx Idylla™ platform is a fully automated sample-to-result, real-time PCR (Polymerase Chain Reaction) system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting. Biocartis is developing and marketing a continuously expanding test menu addressing key unmet clinical needs, with a focus in oncology. This represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer. More information: www.biocartis.com

information-icon-6058.png
counter-575944_1280.png
Idylla™_system_1_instr.png
Symposium - Soon to stream on demand!
Symposiums ISLB CONGRESS 2020 (2).png
Register for the Symposium

Thanks for your registration!

Contact us:
BIOCARTIS LOGO.PNG
arrow&v

Thanks for submitting!